<p> A high-throughput screening was used to identify protein aggregation inhibitors in vitro and in cell culture. Compounds selected in the primary screens were validated in dilution series in order to identify compounds active at very low concentrations. Clustering of the compound hits subsequently revealed a consensus structure common to active protein aggregation inhibitors. This lead structure was further modified to optimize its medicinal-chemical properties. The resulting candidates strongly reduced scrapie prion proteins in cell culture at nanomolar concentrations. They also revealed high therapeutic potential in mice infected with scrapie prions. The same compounds also inhibit formation
firstname.lastname@example.org | TechnologieAllianz e.V.
New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.
Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.
22.05.2017 | Event News
17.05.2017 | Event News
16.05.2017 | Event News
22.05.2017 | Materials Sciences
22.05.2017 | Life Sciences
22.05.2017 | Physics and Astronomy